Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin

Cell Reports

Volumn 2, Issue 4, 2012, Pages 889-901

  Samson, Andre L ^a,b   Knaupp, Anja S ^b   Sashindranath, Maithili ^a   Borg, Rachael J ^a   Au, Amanda E L ^a   Cops, Elisa J ^a   Saunders, Helen M ^b   Cody, Stephen H ^b   McLean, Catriona A ^c   Nowell, Cameron J ^d   Hughes, Victoria A ^b   Bottomley, Stephen P ^b   Medcalf, Robert L ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 90; PLASMIN; PLASMINOGEN; SCAFFOLD PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELLULAR SECRETION; CONTROLLED STUDY; DISULFIDE BOND; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NONHUMAN; NUCLEOCYTOPLASMIC COAGULATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN METABOLISM;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DISULFIDES; FIBRINOLYSIN; HUMANS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; NEURONS; PLASMINOGEN; PROTEOLYSIS; TISSUE PLASMINOGEN ACTIVATOR; TUBULIN;

MUS;

EID: 84868145931     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.08.026     Document Type: Article

References (41)

1. Bergemalm D., Forsberg K., Srivastava V., Graffmo K.S., Andersen P.M., Brännström T., Wingsle G., Marklund S.L. Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. J. Neurochem. 2010, 114:408-418.
2. Brennan J.P., Wait R., Begum S., Bell J.R., Dunn M.J., Eaton P. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J. Biol. Chem. 2004, 279:41352-41360.
3. Brown A.W., Brierley J.B. Anoxic-ischaemic cell change in rat brain light microscopic and fine-structural observations. J. Neurol. Sci. 1972, 16:59-84.
4. Castellino F.J., Ploplis V.A. Structure and function of the plasminogen/plasmin system. Thromb. Haemost. 2005, 93:647-654.
5. Cumming R.C., Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J. 2005, 19:2060-2062.
6. Cumming R.C., Andon N.L., Haynes P.A., Park M., Fischer W.H., Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 2004, 279:21749-21758.
7. Derman A.I., Prinz W.A., Belin D., Beckwith J. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 1993, 262:1744-1747.
8. Eaton P., Byers H.L., Leeds N., Ward M.A., Shattock M.J. Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J. Biol. Chem. 2002, 277:9806-9811.
9. Fernández-Monreal M., López-Atalaya J.P., Benchenane K., Léveillé F., Cacquevel M., Plawinski L., MacKenzie E.T., Bu G., Buisson A., Vivien D. Is tissue-type plasminogen activator a neuromodulator?. Mol. Cell. Neurosci. 2004, 25:594-601.
10. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., Bonetto V., Mengozzi M., Duffieux F., Miclet E., et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA 2002, 99:3505-3510.
11. Gebbink M.F. Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. J. Thromb. Haemost. 2011, 9(Suppl 1):174-181.
12. Hiller G., Weber K. Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues. Cell 1978, 14:795-804.
13. Hu B.R., Janelidze S., Ginsberg M.D., Busto R., Perez-Pinzon M., Sick T.J., Siesjö B.K., Liu C.L. Protein aggregation after focal brain ischemia and reperfusion. J. Cereb. Blood Flow Metab. 2001, 21:865-875.
14. Huang J., Hao L., Xiong N., Cao X., Liang Z., Sun S., Wang T. Involvement of glyceraldehyde-3-phosphate dehydrogenase in rotenone-induced cell apoptosis: relevance to protein misfolding and aggregation. Brain Res. 2009, 1279:1-8.
15. Jacobsen J.S., Comery T.A., Martone R.L., Elokdah H., Crandall D.L., Oganesian A., Aschmies S., Kirksey Y., Gonzales C., Xu J., et al. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc. Natl. Acad. Sci. USA 2008, 105:8754-8759.
16. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 2001, 3:193-197.
17. Johnson V.E., Stewart W., Smith D.H. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?. Nat. Rev. Neurosci. 2010, 11:361-370.
18. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
19. Kayed R., Head E., Sarsoza F., Saing T., Cotman C.W., Necula M., Margol L., Wu J., Breydo L., Thompson J.L., et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2007, 2:18.
20. Kingston I.B., Castro M.J., Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat. Med. 1995, 1:138-142.
21. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982, 239:57-69.
22. Kranenburg O., Bouma B., Kroon-Batenburg L.M., Reijerkerk A., Wu Y.P., Voest E.E., Gebbink M.F. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr. Biol. 2002, 12:1833-1839.
23. Kuhn D.M., Sykes C.E., Geddes T.J., Jaunarajs K.L., Bishop C. Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease. J. Neurochem. 2011, 116:426-437.
24. Ledesma M.D., Da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., Dotti C.G. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep. 2000, 1:530-535.
25. Liao L., Cheng D., Wang J., Duong D.M., Losik T.G., Gearing M., Rees H.D., Lah J.J., Levey A.I., Peng J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 2004, 279:37061-37068.
26. Longstaff C., Thelwell C., Williams S.C., Silva M.M., Szabó L., Kolev K. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies. Blood 2011, 117:661-668.
27. Löwe J., Li H., Downing K.H., Nogales E. Refined structure of alpha beta-tubulin at 3.5 A resolution. J. Mol. Biol. 2001, 313:1045-1057.
28. Maas C., Schiks B., Strangi R.D., Hackeng T.M., Bouma B.N., Gebbink M.F., Bouma B. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Amyloid 2008, 15:166-180.
29. Nakajima H., Amano W., Fujita A., Fukuhara A., Azuma Y.T., Hata F., Inui T., Takeuchi T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J. Biol. Chem. 2007, 282:26562-26574.
30. Nakajima H., Amano W., Kubo T., Fukuhara A., Ihara H., Azuma Y.T., Tajima H., Inui T., Sawa A., Takeuchi T. Glyceraldehyde-3-phosphate dehydrogenase aggregate formation participates in oxidative stress-induced cell death. J. Biol. Chem. 2009, 284:34331-34341.
31. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
32. Radcliffe R., Heinze T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?. Arch. Biochem. Biophys. 1981, 211:750-761.
33. Roussel B.D., Macrez R., Jullienne A., Agin V., Maubert E., Dauphinot L., Potier M.C., Plawinski L., Castel H., Hommet Y., et al. Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 2009, 132:2219-2230.
34. Samson A.L., Nevin S.T., Croucher D., Niego B., Daniel P.B., Weiss T.W., Moreno E., Monard D., Lawrence D.A., Medcalf R.L. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J. Neurochem. 2008, 107:1091-1101.
35. Samson A.L., Borg R.J., Niego B., Wong C.H., Crack P.J., Yongqing T., Medcalf R.L. A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury. Blood 2009, 114:1937-1946.
36. Sashindranath M., Samson A.L., Downes C.E., Crack P.J., Lawrence A.J., Li Q.X., Ng A.Q., Jones N.C., Farrugia J.J., Abdella E., et al. Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation. Lab. Invest. 2011, 91:1079-1091.
37. Sui H., Downing K.H. Structural basis of interprotofilament interaction and lateral deformation of microtubules. Structure 2010, 18:1022-1031.
38. Sultana R., Perluigi M., Butterfield D.A. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol. 2009, 118:131-150.
39. Thornton J.M. Disulphide bridges in globular proteins. J. Mol. Biol. 1981, 151:261-287.
40. Uryu K., Chen X.H., Martinez D., Browne K.D., Johnson V.E., Graham D.I., Lee V.M., Trojanowski J.Q., Smith D.H. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 2007, 208:185-192.
41. Wang Q., Woltjer R.L., Cimino P.J., Pan C., Montine K.S., Zhang J., Montine T.J. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 2005, 19:869-871.